Streit M, Velasco P, Riccardi L, Spencer L, Brown L F, Janes L, Lange-Asschenfeldt B, Yano K, Hawighorst T, Iruela-Arispe L, Detmar M
Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Charlestown, MA 02129, USA.
EMBO J. 2000 Jul 3;19(13):3272-82. doi: 10.1093/emboj/19.13.3272.
The function of the endogenous angiogenesis inhibitor thrombospondin-1 (TSP-1) in tissue repair has remained controversial. We established transgenic mice with targeted overexpression of TSP-1 in the skin, using a keratin 14 expression cassette. TSP-1 transgenic mice were healthy and fertile, and did not show any major abnormalities of normal skin vascularity, cutaneous vascular architecture, or microvascular permeability. However, healing of full-thickness skin wounds was greatly delayed in TSP-1 transgenic mice and was associated with reduced granulation tissue formation and highly diminished wound angiogenesis. Moreover, TSP-1 potently inhibited fibroblast migration in vivo and in vitro. These findings demonstrate that TSP-1 preferentially interfered with wound healing-associated angiogenesis, rather than with the angiogenesis associated with normal development and skin homeostasis, and suggest that therapeutic application of angiogenesis inhibitors might potentially be associated with impaired wound vascularization and tissue repair.
内源性血管生成抑制剂血小板反应蛋白-1(TSP-1)在组织修复中的作用一直存在争议。我们利用角蛋白14表达盒,建立了皮肤中TSP-1靶向过表达的转基因小鼠。TSP-1转基因小鼠健康且可育,未表现出正常皮肤血管、皮肤血管结构或微血管通透性的任何主要异常。然而,TSP-1转基因小鼠的全层皮肤伤口愈合大大延迟,且与肉芽组织形成减少和伤口血管生成高度减弱有关。此外,TSP-1在体内和体外均能有效抑制成纤维细胞迁移。这些发现表明,TSP-1优先干扰与伤口愈合相关的血管生成,而非与正常发育和皮肤稳态相关的血管生成,并提示血管生成抑制剂的治疗应用可能与伤口血管化受损和组织修复有关。